Bladder cancer is a relatively rare phenomenon in the United States – affecting fewer than 200,000 Americans annually – but can be serious when left untreated. Here, incontinence will be discussed relative to bladder cancer, which is a side effect of both the cancer itself and the treatment.
Incontinence is an uncomfortable subject that affects millions of men and women worldwide. Traditionally, an incontinence sufferer would visit his or her primary physician and then be referred to a urologist, depending on symptom severity. Recently, a number of OB-GYN practices have begun offering incontinence care. Here, whether OB-GYN practices should provide care for incontinent patients will be discussed.
Urodynamic testing is the gold standard for incontinence assessment; however, this method is not without
drawbacks. For instance, data interpretation is reliant on a number of factors, including the clinician’s training, proper use of the equipment, and reproduction of the patient’s symptoms during testing.
Sling Procedures are not a new phenomenon; after all, the original Sling Procedure was performed in 1907 by Von Giordano utilizing a gracilis muscle graft around the urethra. Since then, a number of improvements have been made to the Sling Procedure, particularly in the past 15 years. Sling Procedures over the last decade will be summarized here.
The consequence of incontinence extends far beyond embarrassment. Around 13 million people in the U.S. have been diagnosed with incontinence, according to the Agency for Healthcare Research and Quality. While older age increases the risk of this condition, there are a wide range of factors that can cause this problem in younger persons. Meanwhile, women are much more likely than men to experience incontinence, per the Centers for Disease Control.
As you grow older, problems with losing control of your bladder and bowels can increase. This involuntary loss of control is known as “incontinence”.